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ABSTRACT   
 
BACKGROUND: Tetanus is an acute vaccine preventable illness 
manifested by neuromuscular dysfunction due to a potent exotoxin, 
tetanospasmin produced by Clostridium tetani. It is a common 
health problem in developing countries like Ethiopia. The aim of 
this study was to assess clinical profile and outcome of Pediatrics 
tetanus in a referral hospital, South Ethiopia.  
METHODS: This is a retrospective cross-sectional study of medical 
records of 24 Pediatric tetanus patients who were admitted from 
July 2014 to June 2016 to the Pediatrics Department of Hawassa 
University Comprehensive Specialized Hospital, Hawassa-Ethiopia. 
Tetanus was diagnosed clinically. Data were entered and analyzed 
using SPSS statistical software.  
RESULTS: The median age at diagnosis was 8 years with 19 
(79.2%)of the study subjects being males. There were 3 male 
neonatal tetanus cases with 2 deaths. From post-neonatal cases, 
only 8(38.1%) were fully vaccinated for infant Expanded Period of 
Immunization (EPI). Booster vaccination with TT (tetanus toxoid) 
was only given to 5(29.4%) of discharged patients. Trauma was 
common in above 5 years of age and documented in 19(79.2%) of 
patients. All tetanus cases were generalized type with mild, 
moderate and severe grades comprising 7(29.2%), 8(33.3%), 
7(29.2%) and 2(8.3%) respectively. Case fatality rate was 29.2% (7) 
with more deaths in higher grades. Respiratory failure 6(85.7%), 
and aspiration pneumonia 1(14.3%) were causes of death. 
CONCLUSION: In this study, case fatality rate was high. Hence, 
health promotion with scale-up of EPI for infant tetanus 
immunization and large scale studies to provide support for booster 
vaccination schedules are recommended.  




Tetanus, a vaccine preventable disease, is an acute illness manifested 
by neuromuscular dysfunction due to a potent exotoxin, 
tetanospasmin produced by Clostridium tetani. Tonic spasms of the 
skeletal muscles with paroxysmal contractions are the typical 
presentations; lockjaw is the initial symptom (1). Tetanus is a clinical 
diagnosis. Neonatal cases are said to be confirmed if an infant with  
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normal ability to suck and cry in the first 2 days 
presents with failure to suck between 3 and 28 
days of life with rigidity or spasms. Tetanus is 
classified as localized, cephalic and generalized 
(2-3).  
Globally, a total of 56,743 deaths were 
reported due to tetanus in 2015:19,937 deaths 
occurred in neonates and 36,806 deaths occurred 
after the neonatal period. From all neonatal tetanus 
deaths, 45% and 44% occurred in South Asia and 
sub-Saharan Africa respectively. Sixty-seven 
(67%) of the sub-Saharan neonatal deaths have 
happened in eastern sub-Saharan Africa. The case 
fatality rates (CFR) of tetanus vary from 10-70%, 
the highest occurring in developing countries. 
Availability of intensive care unit reduces CFR to 
10-20%(4-6).  
Principles of management of tetanus cases 
include admission to dark and quiet room, muscle 
spasm and  rigidity control, autonomic 
dysfunction control, ventilator support when 
needed, neutralization of tetanus toxin ,wound 
management,  antibiotics administration and 
prevention of recurrence with booster vaccination. 
Benzodiazepines are still the corner stone for 
sedation and spasm control while magnesium 
sulfate is also currently recommended (3,7). Infant 
tetanus vaccination followed by booster doses and 
proper wound management are disease prevention 
strategies (8-9). 
There is scarcity of studies on Pediatrics 
tetanus from Sub-Saharan Africa and Ethiopia 
particularily. Hence, this study was conducted   to 
analyze clinical characteristics and outcome of 
Pediatrics tetanus cases admitted to Hawassa 





Study setting, design, period and subjects: This 
is a retrospective cross sectional study of medical 
records of 24 Pediatric tetanus patients who were 
admitted from July 2014 to June 2016 to the 
Pediatrics Department of HUCSH, the referral 
hospital for Southern Nations and Nationalities 
Regional State, Hawassa, Ethiopia. Medical 
records of patients were retrieved from medical 
records office and studied. Tetanus was diagnosed 
clinically and classified into localized, cephalic 
and generalized types. Severity was graded by 
Ablett classification into mild, moderate and 
severe (10).  
 
Data collection and analysis: Data was collected 
from medical records of patients by using a data 
collection sheet. Clinical and demographic data 
including age, sex, expanded period of 
immunization (EPI) status, time of onset, outcome 
etc were collected. All data were entered, cleared 
and analyzed using SPSS (statistical package for 
social sciences) version 20. Descriptive statistics 
was used to present data.  
 
Ethical approval: Ethical approval was obtained 
from the Institutional Review Board of the 
College of Medicine and Health Sciences, 




Demographic and clinical profile data: The 
median age at diagnosis was 8 years with range 
from 3 days to 13 years. From documented cases, 
19(79.2%) were males. The majority of patients 
were aged above 5 years. There were 3 male 
neonatal tetanus cases, and one of them had 
associated gastroschisis. For post neonatal cases, 
infant (EPI) vaccination status was complete, 
incomplete, unknown and not vaccination in 
8(38.1%), 2(9.5%), 8(38.1%) and 3(14.3%) 
respectively. Booster vaccination with TT (tetanus 
toxoid) was only given to 5(29.4%) of discharged 
patients (Table 1). Trauma or portal of entry was 
documented in 19(79.2%) of patients. Trauma was 
common above 5 years of age, and tungiasis was 
documented in 5 cases (Table 2). All patients had 
generalized tetanus. Mild, moderate and severe 
grades of tetanus comprised 7(29.2%), 8(33.3%), 
7(29.2%) and 2(8.3%) respectively according to 
Ablett classification (Table 3) 
Dark room isolation, diazepam and 
chlorpromazine as muscle relaxants, debridement 
(for selected cases), pencillin G or metronidazole 
antibiotic and tetanus antitoxoid were given for all 
patients as a standard of care. Only one patient had 
tracheostomy and was admitted to the general 
intensive care unit (ICU).  
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Frequency(N) Percentage (%) 
Age (years) 
< 5 5 20.8 
5-10 10 41.7 
10-13 9 37.5 
Sex 
Male  19 79.2 
Female 5 20.8 
Incubation period in days (n=19)   
< 7 3 15.8 
7-14 7 36.8 
14-28 5 26.3 
>28 4 21.1 
Time of onset in days(n=19)    
< 3 6 31.6 
3-7 6 31.6 
>7 7 36.8 
Maternal TT vaccination- Neonatal cases    
One time 0 0 
Two times and more 2 66.7 
None  1 33.3 
EPI- Post neonatal    
Complete 8 38.1 
Incomplete 2 9.5 
Unknown  8 38.1 
Unvaccinated at all 3 14.3 
Outcome    
Survived  15 62.5 
Died  7 29.2 
Discharged against medical advise  2 8.3 
Cause of death(N=7)   
Aspiration Pneumonia 1 14.3 
Respiratory failure/ uncontrolled spasm 6 85.7 
Booster vaccination on discharge (N= 17)   
Yes 5 29.4 
No 12 70.6 
 
From the neonatal cases, one was born at home, 
and there were 2 neonatal deaths. There was no 
history of umbilical manipulation or traditional 
procedure done at home in neonatal cases.  From 
all admitted cases, 15(62.5%), 7(29.2%), and 
2(8.3%) had survived, died and were discharged 
against medical advice respectively. Causes of 
deaths were respiratory failure , 6(85.7%) and 
aspiration pneumonia, 1(14.3%). The majority of 
the patients with mild to moderate severity grades 
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Posible entry  < 5years old 
N=2 
5-10 years old 
N= 9 
10-13 years old 
N= 8 
 
Metallic material  1 1 3  
Wooden material  0 3 3  
Animal excreta  0 2 1  
Tungiasis  1 3 1  
 
Table 3: Ablett tetanus severity grade, outcome and hospital stay in pediatrics tetanus atHUCSH, 2014-
2016 
 
Variable  Frequency(N) Percentage (%) 
Ablett severity grade 
              I 7 29.2 
             II 8 33.3 
            III 7 29.2 
            IV  2 8.3 
Outcome  
     Survived(n=15)  
            I 6 40 
            II 6 40 
            III 3 20 
            IV  0 0 
    Died(n=7) 
            I 1 14.3 
            II 0 0 
            III 4 57.1 
            IV 2 28.6 
   Discharge against medical advice (n=2) 
           I 0 0 
           II 2 100 
           III 0 0 
           IV 0 0 
Hospital stay in days  
          < 7 7 29.2 
          7-14 7 29.2 
          14-28 8 33.3 




Tetanus has remained a public health problem in 
developing countries with high case fatality rates. 
Efforts of neonatal, childhood and maternal 
elimination through vaccination have faced 
challenges in these parts of the world due to low 
health awareness, shortage of human and material 
resources and poor health seeking behaviour for 
trauma. Due to the very nature of tetanus, hospital 
based studies are found to be an effective means 
for collecting information on the epidemiologic 
and clinical data on neonatal and childhood 
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tetanus, and also for evaluating the impact of 
immunization programs (11-13).  
In this study, children aged 5 years and above 
were found to be highly affected with a male 
predominance. This could be due to disappearance 
of protection from infant tetanus immunization 
and tendency of boys to engage in outdoor and 
rough competitive games. This is in agreement 
with other similar studies done in developing 
countries(8,14-17).  
In this tudy, trauma is documented to be the 
most common portal of entry in 19(79.2%) of 
patients. This could be explained by the high 
chance of ignoring Pediatric trauma and lack of 
provision of tetanus prophylaxis for healthcare 
seeking patients.This finding is higher than the 
finding from studies done in Nigeria, India and 
Nepal but comparable with a study done in 
Senegal. Differences could be explained by the 
differences in number of participants and Pediatric 
age range included in the studies (15-16,18-19).  
In this study, only 8(38.1%) of cases were fully 
vaccinated according to EPI schedule, and only 
5(29.4%) of discharged patients received TT 
vaccine on discharge. This could be explained by 
the low national EPI coverage, low awareness 
among professionals and lack of national policy 
on TT booster vaccination. Tetanus will not offer 
a lifelong immunity.This finding is consistent with 
the Ethiopian demographic survey report and other 
studies (8,18,20). 
In this study, it was found that the majority of 
patients had mild and moderate tetanus and 
outcome was poor in higher grades. Case fatality 
rate was 29.2%, and the most common cause of 
death was respiratory failure secondary to 
uncontrolled spasm. This could be due to poor 
escalation of muscle relaxants and lack of 
Pediatric ICU care, a service which is limited in 
our hospital. This finding is comparable with 
findings of other similar studies (16,18,21).  
The main limitation of this study is lack of 
more detailed clinical information and statistical 
analysis on factors affecting mortality. There is a 
need for better documentation and medical records 
keeping. However, this study provides clinical 
profile and outcome of Pediatrics tetanus in 
HUCSH which serves as baseline information. It 
can also be used for planning targeted prevention 
strategies in the study and similar settings.  
In conclusion, this study has documented 
high case fatality rates in Pediatric tetanus in the 
study area. Closer follow-up of patients to identify 
the progress of severity assists in identifying cases 
that require respiratory support and drug 
escalation. Hence, health promotion with scale up 
of EPI for infant tetanus immunization and large 
scale studies to provide support for booster 
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